William S. Krimsky, MD, FCCP, DAABIP
Chief Medical Officer
William Krimsky is Chief Medical Officer of Galvanize Therapeutics. Bill has been a pioneer in the Interventional Pulmonology space for more than 20 years, carving an innovative pathway for the treatment of lung diseases. In 2015, he and Jonathan Waldstreicher co-founded Galvanize Therapeutics and co-invented the Aliya® and RheOx® technologies, continuing his focus on therapeutic intervention in the pulmonary and oncology fields. Bill earned his medical degree at the University of Pittsburgh School of Medicine and completed an internship at Mercy Hospital and a residency at Johns Hopkins University/Sinai Hospital. Following that, he was a fellow in pulmonary and critical care medicine at Dartmouth-Hitchcock Medical Center and a visiting fellow in Interventional Pulmonology at the Hospital of the University of Pennsylvania. He is the author of multiple publications.